KD033 (SAR445710)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for KD033 (SAR445710), covering 2025-09-16 to 2025-09-16. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of KD033 (SAR445710) in Subjects With Metastatic or Locally Advanced Solid Tumors [Phase 1]